We conclude that the glycocalyx is degraded in a variety of health conditions, although it
remains to be determined whether glycocalyx degradation plays a causal role in disease …

Results A total of 25 manuscripts out of 304 identified studies were selected. There were 15
(60%) multicenter or nationwide studies. The data about the incidence rate of T1D …

Damage of the endothelial glycocalyx (eGC) plays a central role in the development of
vascular hyperpermeability and organ damage during systemic inflammation. However, the …

In March 2020, the World Health Organization (WHO) announced a global pandemic of
coronavirus disease 2019 (COVID-19) that presented mainly as an acute infection of the …

Abstract Coronavirus disease 2019 (COVID-19) is still causing hospitalization and death,
and vaccination appears to become less effective with each emerging variant. Spike, non …

Damage to the endothelial glycocalyx (eGC) has been reported during acute ischemic
events like ST-elevation myocardial infarction (STEMI). In STEMI, a door-to-balloon time …

The coronavirus disease 2019 (COVID-19) displays a broad spectrum of symptoms, with the
underlying reasons for this variability still not fully elucidated. Our study investigates the …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused a worldwide
pandemic and social and economic upheaval. To date, SARS-CoV-2 has infected more than …

Introduction SARS-CoV-2 infection normally damages respiratory system but may likewise
impair endocrine organs' function. Thyroid dysfunction and hyperglycemia are common …

Background Damage to the endothelial glycocalyx (eGC) and endothelial dysfunction have
been reported to develop during cardiac ischemia-and-reperfusion injury (IRI), such as ST …